142 related articles for article (PubMed ID: 25600546)
1. Flow cytometric assessment of P-glycoprotein and multidrug resistance-associated protein activity and expression in canine lymphoma.
Poźniak B; Pawlak A; Obmińska-Mrukowicz B
In Vivo; 2015; 29(1):149-53. PubMed ID: 25600546
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric evaluation of multidrug resistance proteins on grossly normal canine nodal lymphocyte membranes.
Schleis SE; LeBlanc AK; Neilsen NR; LeBlanc CJ
Am J Vet Res; 2008 Oct; 69(10):1310-5. PubMed ID: 18828688
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes.
Janneh O; Jones E; Chandler B; Owen A; Khoo SH
J Antimicrob Chemother; 2007 Nov; 60(5):987-93. PubMed ID: 17890284
[TBL] [Abstract][Full Text] [Related]
4. Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia.
van der Kolk DM; de Vries EG; Noordhoek L; van den Berg E; van der Pol MA; Müller M; Vellenga E
Leukemia; 2001 Oct; 15(10):1544-53. PubMed ID: 11587212
[TBL] [Abstract][Full Text] [Related]
5. Multi-drug resistance in a canine lymphoid cell line due to increased P-glycoprotein expression, a potential model for drug-resistant canine lymphoma.
Zandvliet M; Teske E; Schrickx JA
Toxicol In Vitro; 2014 Dec; 28(8):1498-506. PubMed ID: 24975508
[TBL] [Abstract][Full Text] [Related]
6. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
7. Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1.
Sun M; Xu X; Lu Q; Pan Q; Hu X
Cancer Lett; 2007 Feb; 246(1-2):300-7. PubMed ID: 16621244
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir.
Janneh O; Anwar T; Jungbauer C; Kopp S; Khoo SH; Back DJ; Chiba P
Antivir Ther; 2009; 14(7):965-74. PubMed ID: 19918100
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2, P-glycoprotein and multi-drug resistance-associated protein in canine transitional cell carcinoma.
Lee JY; Tanabe S; Shimohira H; Kobayashi Y; Oomachi T; Azuma S; Ogihara K; Inokuma H
Res Vet Sci; 2007 Oct; 83(2):210-6. PubMed ID: 17316722
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of phenothiazines on MRP1 and P-glycoprotein activity.
Wesołowska O; Molnar J; Ocsovszki I; Michalak K
In Vivo; 2009; 23(6):943-7. PubMed ID: 20023237
[TBL] [Abstract][Full Text] [Related]
11. The fluorescent probe Bodipy-FL-verapamil is a substrate for both P-glycoprotein and multidrug resistance-related protein (MRP)-1.
Crivellato E; Candussio L; Rosati AM; Bartoli-Klugmann F; Mallardi F; Decorti G
J Histochem Cytochem; 2002 May; 50(5):731-4. PubMed ID: 11967284
[TBL] [Abstract][Full Text] [Related]
12. Comparison of drug efflux transport kinetics in various blood-brain barrier models.
Bachmeier CJ; Trickler WJ; Miller DW
Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372
[TBL] [Abstract][Full Text] [Related]
13. Antitumour effect and modulation of expression of the ABCB1 gene by perifosine in canine lymphoid tumour cell lines.
Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2014 Jul; 201(1):83-90. PubMed ID: 24881508
[TBL] [Abstract][Full Text] [Related]
14. Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers.
Brayden DJ; Griffin J
Vet Res Commun; 2008 Jan; 32(1):93-106. PubMed ID: 17578674
[TBL] [Abstract][Full Text] [Related]
15. The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line.
Ferreira MJ; Gyémánt N; Madureira AM; Tanaka M; Koós K; Didziapetris R; Molnár J
Anticancer Res; 2005; 25(6B):4173-8. PubMed ID: 16309213
[TBL] [Abstract][Full Text] [Related]
16. Expressions of multidrug resistance protein 1 and multidrug resistance-associated protein 1 in lung dendritic cells.
Hasegawa H; Inui N; Suda T; Shibata K; Nakamura Y; Watanabe H; Nakamura H; Chida K
Life Sci; 2011 Aug; 89(7-8):282-7. PubMed ID: 21763326
[TBL] [Abstract][Full Text] [Related]
17. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis.
Kubota H; Ishihara H; Langmann T; Schmitz G; Stieger B; Wieser HG; Yonekawa Y; Frei K
Epilepsy Res; 2006 Mar; 68(3):213-28. PubMed ID: 16361082
[TBL] [Abstract][Full Text] [Related]
18. Effects of plant sterols on human multidrug transporters ABCB1 and ABCC1.
Nabekura T; Yamaki T; Ueno K; Kitagawa S
Biochem Biophys Res Commun; 2008 May; 369(2):363-8. PubMed ID: 18280247
[TBL] [Abstract][Full Text] [Related]
19. Dehydrothyrsiferol does not modulate multidrug resistance-associated protein 1 resistance: a functional screening system for MRP1 substrates.
Pec MK; Aguirre A; Fernández JJ; Souto ML; Dorta JF; Villar J
Int J Mol Med; 2002 Nov; 10(5):605-8. PubMed ID: 12373300
[TBL] [Abstract][Full Text] [Related]
20. Expression and activity of multidrug resistance protein 1 in a murine thymoma cell line.
Echevarria-Lima J; Kyle-Cezar F; P Leite DF; Capella L; Capella MA; Rumjanek VM
Immunology; 2005 Apr; 114(4):468-75. PubMed ID: 15804283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
